Nuclera
Nuclera accelerates protein expression and purification workflows through its benchtop protein system, eProtein Discovery, enabling rapid access to proteins for drug discovery research. The system automates processes, reducing time and cost, and providing high-quality proteins at scale. This speeds up research in labs using AI for protein design.
Buy Funded Startups lists
Funding Round: Series C
Funding Amount: $75M
Date: 16-Oct-2024
Investors: Elevage Medical Technologies, Patient Square Capital, British Patient Capital, Cambridge Innovation Capital, Jonathan Milner, GK Goh, M&G Catalyst, E Ink Holdings, Michael D. McCreary, Uni Power Group, Verve Ventures
Markets: Biotech, Life Science, Pharmaceutical
HQ: Cambridge, Cambridgeshire, United Kingdom
Founded: 2013
Website: https://www.nuclera.com/
LinkedIn: https://www.linkedin.com/company/nuclera
Twitter: https://twitter.com/nuclera
Crunchbase: https://www.crunchbase.com/organization/nuclera
Leave a Comment
Comments
No comments yet.